Genomics

Dataset Information

0

Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363

ABSTRACT: Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363

PROVIDER: PRJNA977979 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR24772200_1.fastq.gz Fastqsanger.gz
SRR24772200_2.fastq.gz Fastqsanger.gz
SRR24773500_1.fastq.gz Fastqsanger.gz
SRR24773500_2.fastq.gz Fastqsanger.gz
SRR24772201_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 438

Similar Datasets

Transcriptomics Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363 [BrU-Seq]
2023-06-05 | GSE233787 | GEO
Genomics Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363 [ATAC-Seq]
2023-06-05 | GSE233784 | GEO
Transcriptomics Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363 [RNA-Seq]
2023-06-05 | GSE233783 | GEO
Genomics Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363 [ChIP-Seq - CUT&RUN]
2023-06-05 | GSE233788 | GEO
Genomics Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363 [ATAC-Seq]
| PRJNA977984 | ENA
Genomics Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363 [BrU-Seq]
| PRJNA977985 | ENA
Genomics Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363 [RNA-Seq]
| PRJNA977982 | ENA
Genomics Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363 [ChIP-Seq - CUT&RUN]
| PRJNA977987 | ENA
Transcriptomics Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363
2023-06-05 | GSE233789 | GEO
Transcriptomics Identification of KAT6B signature on KAT6B deficient SCLC cell Lines
2015-10-07 | GSE59136 | GEO